Approval · Notice of Compliance 5009 · 1995
ETHRANE: Notice of Compliance 5009
Issued October 31, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5009
- Date
- October 31, 1995
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Inhalation anaesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETHRANE | 02188899 | Cancelled Post Market |
Medicinal ingredients
- ENFLURANE 100 PER